Search

Your search keyword '"Merck Sharp & Dohme Corp. -- Intellectual property"' showing total 21 results
Start Over Descriptor "Merck Sharp & Dohme Corp. -- Intellectual property" Journal cancer weekly
21 results on '"Merck Sharp & Dohme Corp. -- Intellectual property"'

1. Researchers Submit Patent Application, 'Inhibitors Of Histone Deacetylase-3 Useful For The Treatment Of Cancer, Inflammation, Neurodegeneration Diseases And Diabetes', for Approval (USPTO 20220177465)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Diabetes therapy -- Intellectual property, Inflammation, Antiviral agents, Anti-HIV agents, Cancer -- Care and treatment, Darunavir, Atazanavir -- Intellectual property, Type 2 diabetes, Pharmaceutical industry -- Intellectual property, Business, Health, Health care industry
Abstract

2022 JUN 28 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors KELLY, Joseph [...]

Published
2022

2. Patent Issued for Combinations of PD-1 antagonists and benzo [b] thiophene STING agonists for cancer treatment (USPTO 11312772)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Thiophene -- Reports, Cancer -- Care and treatment, Bites and stings -- Reports, Pharmaceutical industry -- Intellectual property, Business, Health, Health care industry
Abstract

2022 MAY 17 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- From Alexandria, Virginia, NewsRx journalists report that a patent by the inventors Cemerski, Saso (Norfolk, [...]

Published
2022

3. Patent Issued for Benzo[b]thiophene STING agonists for cancer treatment (USPTO 11285131)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Thiophene, Cancer -- Care and treatment, Bites and stings, Pharmaceutical industry -- Intellectual property, Business, Health, Health care industry
Abstract

2022 APR 19 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- A patent by the inventors Cemerski, Saso (Norfolk, MA, US), Cumming, Jared N. (Winchester, MA, [...]

Published
2022

4. 'Stable Formulations of Programmed Death Receptor 1 (PD-1) Antibodies and Hyaluronidase Variants and Fragments Thereof and Methods of Use Thereof' in Patent Application Approval Process (USPTO 20220089738)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Amino acids -- Intellectual property -- Methods, Pharmaceutical industry -- Intellectual property, Business, Health, Health care industry
Abstract

2022 APR 12 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- A patent application by the inventors Forrest, JR., William P. (Middletown, NJ, US); Krishnamachari, Yogita [...]

Published
2022

5. Researchers Submit Patent Application, 'Antibodies Specific For Immunoglobulin-Like Transcript 3 (Ilt3) And Uses Thereof', for Approval (USPTO 20220033497)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Biological products -- Intellectual property, Viral antibodies, Amino acids -- Intellectual property, Antibodies, Pharmaceutical industry -- Intellectual property, Business, Health, Health care industry
Abstract

2022 FEB 22 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors Brandish, Philip [...]

Published
2022

6. Researchers Submit Patent Application, 'Antibodies Specific For Immunoglobulin-Like Transcript 3 (Ilt3) And Uses Thereof', for Approval (USPTO 20220025043)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Biological products -- Intellectual property, Viral antibodies, Amino acids -- Intellectual property, Antibodies, Pharmaceutical industry -- Intellectual property, Business, Health, Health care industry
Abstract

2022 FEB 15 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors Brandish, Philip [...]

Published
2022

7. Patent Application Titled 'Antibodies Specific For Immunoglobulin-Like Transcript 3 (Ilt3) And Uses Thereof' Published Online (USPTO 20220025042)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Biological products -- Intellectual property, Viral antibodies, Amino acids -- Intellectual property, Antibodies, Pharmaceutical industry -- Intellectual property, Business, Health, Health care industry
Abstract

2022 FEB 15 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application by [...]

Published
2022

8. Researchers Submit Patent Application, 'Antibodies Specific For Immunoglobulin-Like Transcript 3 (Ilt3) And Uses Thereof', for Approval (USPTO 20220010011)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Biological products -- Intellectual property, Viral antibodies, Amino acids -- Intellectual property, Antibodies, Monoclonal antibodies, Pharmaceutical industry -- Intellectual property, Business, Health, Health care industry
Abstract

2022 FEB 1 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors Brandish, Philip [...]

Published
2022

9. Patent Application Titled 'Antibodies Specific For Immunoglobulin-Like Transcript 3 (Ilt3) And Uses Thereof' Published Online (USPTO 20220010010)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Biological products -- Intellectual property, Viral antibodies, Amino acids -- Intellectual property, Antibodies, Pharmaceutical industry -- Intellectual property, Business, Health, Health care industry
Abstract

2022 FEB 1 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application by [...]

Published
2022

10. Researchers Submit Patent Application, 'Anti-Ilt4 Antibodies And Antigen-Binding Fragments', for Approval (USPTO 20220002403)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Biological products -- Intellectual property, Viral antibodies, Antigens, Amino acids -- Intellectual property, Antibodies, Pharmaceutical industry -- Intellectual property, Business, Health, Health care industry
Abstract

2022 JAN 25 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors Blanusa, Milan [...]

Published
2022

11. Patent Application Titled 'Co-Formulations Of Anti-Lag3 Antibodies And Anti-Pd-1 Antibodies' Published Online (USPTO 20220002410)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Biological products -- Intellectual property, Viral antibodies, Amino acids -- Intellectual property, B cells, Palladium -- Intellectual property, Antibodies, Pharmaceutical industry -- Intellectual property, Business, Health, Health care industry
Abstract

2022 JAN 25 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application by [...]

Published
2022

12. Patent Application Titled 'Stable Formulations Of Programmed Death Receptor 1 (Pd-1) Antibodies And Methods Of Use Thereof' Published Online (USPTO 20210380694)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Amino acids -- Methods -- Intellectual property, Palladium -- Methods -- Intellectual property, Pharmaceutical industry -- Intellectual property, Business, Health, Health care industry
Abstract

2021 DEC 28 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application by [...]

Published
2021

13. Patent Issued for Antibodies specific for immunoglobulin-like transcript 3 (ILT3) and uses thereof (USPTO 11111297)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Biological products -- Intellectual property -- Reports, Viral antibodies -- Reports, Amino acids -- Reports -- Intellectual property, Antibodies -- Reports, Pharmaceutical industry -- Intellectual property, Business, Health, Health care industry
Abstract

2021 SEP 28 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- From Alexandria, Virginia, NewsRx journalists report that a patent by the inventors Brandish, Philip E. [...]

Published
2021

14. Patent Issued for Anti-PD-1/LAG3 bispecific antibodies (USPTO 11072658)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Biological products -- Intellectual property, Viral antibodies, Amino acids -- Intellectual property, Antibodies, Pharmaceutical industry -- Intellectual property, Business, Health, Health care industry
Abstract

2021 AUG 17 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Merck Sharp & Dohme Corp. (Rahway, New Jersey, United States) has been issued patent number [...]

Published
2021

15. Patent Issued for Anti-ILT4 antibodies and antigen-binding fragments (USPTO 11053315)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Biological products -- Intellectual property -- Reports, Viral antibodies -- Reports, Antigens -- Reports, Amino acids -- Reports -- Intellectual property, Antibodies -- Reports, Pharmaceutical industry -- Intellectual property, Business, Health, Health care industry
Abstract

2021 JUL 27 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- From Alexandria, Virginia, NewsRx journalists report that a patent by the inventors Blanusa, Milan (Jena, [...]

Published
2021

16. Patent Issued for Aminopyrazoles As Janus Kinase Inhibitors (USPTO 10,766,883)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Baricitinib -- Intellectual property, Protein kinases, Amino acids -- Intellectual property, Mutual fund industry -- Intellectual property, Tofacitinib, Pharmaceutical industry -- Intellectual property, Anemia, Business, Health, Health care industry
Abstract

2020 SEP 22 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- According to news reporting originating from Alexandria, Virginia, by NewsRx journalists, a patent by the [...]

Published
2020

17. Researchers Submit Patent Application, 'Compositions Of Fosaprepitant And Methods Of Preparation', for Approval (USPTO 20190350947)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Pharmaceutical industry -- Intellectual property -- Methods, EDTA -- Methods, Aprepitant -- Methods, Marketing, Editors, Business, Health, Health care industry, Emend (Medication)
Abstract

2019 DEC 10 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors Yu, Jianwei [...]

Published
2019

18. 'Formulations Of Engineered Anti-Il-10 Antibodies' in Patent Application Approval Process (USPTO 20190010224)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Pharmaceutical industry -- Intellectual property, Biological products, Amino acids, B cells, Antibodies, Editors, Business, Health, Health care industry
Abstract

2019 JAN 29 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- A patent application by the inventors Narasimhan, Chakravarthy Nachu (Scotch Plains, NJ); Basarkar, Ashwin (Keasbey, [...]

Published
2019

19. Patent Issued for Antibodies That Bind to Human Programmed Death Ligand 1 (PD-L1) (USPTO 9709568)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Patents, Amino acids, Antibodies, Pharmaceutical industry -- Intellectual property, Biological products, Patent/copyright issue, Business, Health, Health care industry
Abstract

2017 AUG 1 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- A patent by the inventors Pierce, Robert H. (La Jolla, CA); Bourne, Patricia (Palo Alto, [...]

Published
2017

20. Patent Issued for Inhibitors of Phosphoinositide Dependent Kinase 1 (PDK1)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Cancer, Patents, Pharmaceutical industry -- Intellectual property, Patent/copyright issue, Business, Health, Health care industry
Abstract

By a News Reporter-Staff News Editor at Cancer Weekly -- A patent by the inventors Keenan, Kevin A. (Watertown, MA); Northrup, Alan B. (Reading, MA), filed on November 24, 2009, [...]

Published
2013

21. Patent Issued for Primary Amine Diazeniumdiolate Heterocyclic Derivatives

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Pyridine, Cancer, Patents, Amines, Pharmaceutical industry -- Intellectual property, Patent/copyright issue, Business, Health, Health care industry
Abstract

By a News Reporter-Staff News Editor at Cancer Weekly -- A patent by the inventors Ali, Amjad (Freehold, NJ); Lo, Michael Man-Chu (Edison, NJ); Guo, Zhiqiang (Morganville, NJ); Whitehead, Brent [...]

Published
2013

Catalog

Books, media, physical & digital resources
See catalog results